510(k) Report

510(k) · Cleared

Cleared

Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Aqua Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Violet Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Dark Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Dark Violet Blue

K254285510(k) SpecialCleared Jul 20, 2026201-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hartalega NGC Sdn. Bhd. · LZA Polymer Patient Examination Glove

Cleared on Jul 20, 2026 as substantially equivalent to K162923 (Hartalega NGC Sdn. Bhd., 2017) after a 201-day review. Its family tree reaches back 1 generation to 2017.

Decided
Jul 20, 2026
Review
201 days
Class
Class I
Product code
LZA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K162923 (2017). No later device cites it as a predicate yet.

  1. Root · 1 generation backK162923 Nitrile Powder Free Examination Glove Tested for Use with…Hartalega NGC Sdn. Bhd. · 2017
  2. This deviceK254285 Nitrile Powder Free Examination Gloves Tested for Use with…Hartalega NGC Sdn. Bhd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K162923Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs -…Hartalega NGC Sdn. Bhd.2017—
0 (this device)K254285Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs…Hartalega NGC Sdn. Bhd.2026—
FIG. 1 — Lineage of K254285, 2017–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZA device

  1. #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K162923Nitrile Powder Free Examination Glove Tested for Use with Chemotherapy Drugs - Aqua…
Summary page 7
…: LZA, LZC, OPJ Regulation Number : 21 CFR 880.6250 PREDICATE DEVICE INFORMATION: 510(k) Number : K162923 Manufacturer : Hartalega NGC Sdn. Bhd. Trade Name (Proprietary Name) : Nitrile Powder…
Hartalega NGC Sdn. Bhd.2017—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All LZA devices

LZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · LZA

24in 2025

2007: 212008: 182009: 282010: 312011: 262012: 332013: 202014: 272015: 202016: 302017: 442018: 222019: 252020: 302021: 1392022: 1462023: 622024: 302025: 242026 (partial year): 15
2007high 146 (2022) · low 18 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZA

110in 2025

2007: 95 days median2008: 97 days median2009: 112 days median2010: 97 days median2011: 122 days median2012: 110 days median2013: 130 days median2014: 197 days median2015: 112 days median2016: 171 days median2017: 124 days median2018: 178 days median2019: 212 days median2020: 101 days median2021: 111 days median2022: 111 days median2023: 92 days median2024: 89 days median2025: 110 days median2026 (partial year): 103 days median
2007high 212 (2019) · low 89 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZA

3so far in 2026, the most since 2007

2015: 12016: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZA

73in 2025

2007: 72008: 22009: 122010: 122011: 92012: 112013: 102014: 82015: 122016: 252017: 42018: 32019: 212020: 42021: 202022: 192023: 242024: 762025: 73
2007high 76 (2024) · low 2 (2008)2025

MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007219507
2008189702
200928112012
20103197012
20112612209
201233110011
201320130010
20142719708
201520112112
201630171125
20174412404
20182217803
201925212021
20203010104
2021139111020
2022146111019
20236292024
20243089076
202524110073
2026151033—

What is it indicated for?

Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Aqua Blue is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs. The list of Chemotherapy Drugs tested (with breakthrough time) are: Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time Minutes…

Read the full statement (423 words)

Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Aqua Blue is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs.

The list of Chemotherapy Drugs tested (with breakthrough time) are:

Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time Minutes

Carmustine (3.3 mg/ml) 10.3

Cisplatin (1.0 mg/ml) >240

Cyclophosphamide (20.0 mg/ml) >240

Dacarbazine (10.0 mg/ml) >240

Doxorubicin Hydrochloride (2.0 mg/ml) >240

Etoposide(Toposar)(20.0 mg/ml) >240

Fluorouracil (50.0 mg/ml) >240

Methotrexate (25.0 mg/ml) >240

Mitomycin C (0.5 mg/ml) >240

Paclitaxel (6.0 mg/ml) >240

Thiotepa (10.0 mg/ml) 28.8

Vincristine Sulfate (1.0 mg/ml) >240

Caution: Testing showed a minimum breakthrough time of 10.3 minutes with Carmustine and 28.8 minutes with Thiotepa.

Warning: Do not use with Carmustine and Thiotepa.

Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Violet Blue is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs.

The list of Chemotherapy Drugs tested (with breakthrough time) are:

Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time Minutes

Carmustine (3.3 mg/ml) 10.2

Cisplatin (1.0 mg/ml) >240

Cyclophosphamide (20.0 mg/ml) >240

Dacarbazine (10.0 mg/ml) >240

Doxorubicin Hydrochloride (2.0 mg/ml) >240

Etoposide(Toposar)(20.0 mg/ml) >240

Fluorouracil (50.0 mg/ml) >240

Methotrexate (25.0 mg/ml) >240

Mitomycin C (0.5 mg/ml) >240

Paclitaxel (6.0 mg/ml) >240

Thiotepa (10.0 mg/ml) 30.2

Vincristine Sulfate (1.0 mg/ml) >240

Caution: Testing showed a minimum breakthrough time of 10.2 minutes with Carmustine and 30.2 minutes with Thiotepa.

Warning: Do not use with Carmustine and Thiotepa.

Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Dark Blue is a non-sterile disposable device intended for medical purpose that is worn on the examiner's hand to prevent contamination between patient and examiner. It is also tested to be used against Chemotherapy Drugs.

The list of Chemotherapy Drugs tested (with breakthrough time) are:

Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time Minutes

Carmustine (3.3 mg/ml) 7.3

Cisplatin (1.0 mg/ml) >240

Cyclophosphamide (20.0 mg/ml) >240

Dacarbazine (10.0 mg/ml) >240

Doxorubicin Hydrochloride (2.0 mg/ml) >240

Etoposide(Toposar)(20.0 mg/ml) >240

Fluorouracil (50.0 mg/ml) >240

Methotrexate (25.0 mg/ml) >240

Mitomycin C (0.5 mg/ml) >240

Paclitaxel (6.0 mg/ml) >240

Thiotepa (10.0 mg/ml) 20.6

Vincristine Sulfate (1.0 mg/ml) >240

Caution: Testing showed a minimum breakthrough time of 7.3 minutes with Carmustine and 20.6 minutes with Thiotepa.

Warning: Do not use with Carmustine and Thiotepa.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K254285: Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Aqua Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Violet Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Dark Blue; Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs – Dark Violet Blue.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K254285

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026